Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 32NIH 4NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Classical hematology 2

Conditions

Leukemia 33Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Lymphoma 24Burkitt Lymphoma 14Leukemia, Biphenotypic, Acute 10Urinary Bladder Neoplasms 7Breast Neoplasms 7Lymphoma, Large B-Cell, Diffuse 6Leukemia, Myeloid, Acute 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Myelodysplastic Syndromes 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Leukemia, Lymphocytic, Chronic, B-Cell 4Dendritic Cell Sarcoma, Interdigitating 4Urethral Neoplasms 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Osteosarcoma 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Follicular 3Leukemia, Myelomonocytic, Chronic 3Anemia, Refractory, with Excess of Blasts 3Sarcoma 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Mycosis Fungoides 2Medulloblastoma 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Promyelocytic, Acute 2

Interventions

Whole-Body Irradiation 2Thioguanine 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Methotrexate 2Daunorubicin 2Cytarabine 2Asparaginase 2ruxolitinib 1merphos 1hydrocortisone hemisuccinate 1fludarabine phosphate 1fludarabine 1asparaginase erwinia chrysanthemi recombinant 1Watchful Waiting 1Tacrolimus 1Stem Cell Transplantation 1Radiotherapy 1Photopheresis 1Pentostatin 1Patient Reported Outcome Measures 1Moxifloxacin 1Morphine 1Mitoxantrone 1Methoxsalen 1Mesna 1Melphalan 1Leyk 1In Situ Hybridization, Fluorescence 1Hydrocortisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Myeloproliferative Disorders × Methotrexate × Clear all
NCT00045305 2023-06-28

Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes

Eastern Cooperative Oncology Group

Phase 2 Completed
17 enrolled 10 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00003593 2013-06-27

Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome

Children's Oncology Group

Phase 3 Completed
254 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡